BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• JHL Biotech Proposes Voluntary Delisting from Taiwan Exchange

  The biosimilar company, which has a $419M market capitalization, operates in Taiwan and Wuhan, China.

  December 22, 2017

   · 

  1 min read
• 

  Deals

  Roche Does Last-Minute Christmas Shopping, Drops $1.7 Billion on San Diego Biotech

  Roche got in some last-minute Christmas shopping, shelling out $1.7B for San Diego’s Ignyta.

  December 22, 2017

   · 

  2 min read

   · 

  Mark Terry
• 

  Biocon’s Biosimilar Arm May Raise $500M to Fund Clinical Development

  Biotechnology major BioCon is likely to take its group entity Biocon Biologics public and is expected to raise about $500M.

  December 22, 2017

   · 

  1 min read
• 

  Drug Development

  Zhejiang Medicine Terminates Phase III Oncology Trial

  Zhejiang Medicine has terminated its Phase III oncology trial for oral forms of prochloridine mesylate to treat AML due to a lack of efficacy.

  December 22, 2017

   · 

  2 min read

   · 

  Alex Keown
• 

  Policy

  North Carolina Sues Insys Accused of Bribing Doctors to Prescribe Powerful Opioid Spray

  North Carolina sued Insys on Thursday, accusing the pharmaceutical company of illegally pushing a powerful fentanyl-based cancer pain medicine called Subsys to boost profits amid the U.S. opioid epidemic.

  December 22, 2017

   · 

  1 min read
• Business

  AbSci Appoints Fred Larimore, PhD to Scientific Advisory Board

  Prior to formally joining AbSci’s Scientific Advisory Board, Dr. Larimore advised AbSci on various aspects of biopharmaceutical process development manufacturing scale-up.

  December 22, 2017

   · 

  2 min read
• Drug Development

  Clover Biopharmaceuticals Receives CFDA Approval to Initiate Clinical Trials in China with Etanercept Biosimilar Candidate SCB-808

  A phase I clinical trial is planned to initiate in China in mid-2018.

  December 22, 2017

   · 

  2 min read
• Biotech Bay

  Fluidigm Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

  Fluidigm today announced that the Compensation Committee of its Board of Directors, which is comprised entirely of independent directors, granted an equity award on December 15, 2017.

  December 22, 2017

   · 

  2 min read
• Genetown

  Proteostasis Therapeutics Announces Completion of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares

  Net proceeds from this offering were approximately $42.9M, after deducting underwriting discounts and commissions and estimated offering expenses.

  December 22, 2017

   · 

  4 min read
• Serendipity Ixora Proposes Distribution of its Xbrane Shares to its Shareholders, After Which Serendipity Group Becomes the Largest Shareholder in Xbrane if the Distribution is Executed

  Xbrane Biopharma informs that the Company’s largest shareholder Serendipity, intends to distribute all its shares in Xbrane to its shareholders.

  December 22, 2017

   · 

  3 min read